Contains fulltext : 70338.pdf (publisher's version ) (Open Access)The objective of this thesis was to explore the value and the validity of data collected in daily clinical practice for drug evaluation and cost-effectiveness studies, using data collected on TNFa blocking agents in rheumatoid arthritis. First, the need for and value of information from daily clinical practice was researched. Together, the results of Chapters 3, 4 and 5 illustrated that treatment of RA patients with anti-TNFa blocking agents in daily clinical practice was different from what was expected from the performed RCTs and the guidelines developed on the basis of the RCTs. Data from a daily clinical practice registry can be used to get insight in th...
Objectives: To evaluate costs, benefits, and cost effectiveness of tumour necrosis factor inhibitor ...
Item does not contain fulltextOBJECTIVES: To assess the ability of efficacy measures that incorporat...
It has been found that tumour necrosis factor(TNF)-alpha plays a pivotal role in the pathogenesis of...
Contains fulltext : 65606_evalofned.pdf (publisher's version ) (Open Access)The ob...
The objective of this thesis was to explore the value and the validity of data collected in daily cl...
Contains fulltext : 73433.pdf (publisher's version ) (Open Access)The objective of...
AIM: to evaluate the effects of adalimumab, etanercept and infliximab on disease activity, functiona...
Contains fulltext : 70760.pdf (publisher's version ) (Closed access)Aim: to evalua...
BACKGROUND: Randomised controlled trials (RCTs) evaluating the efficacy of antagonists to tumour nec...
Contains fulltext : 47600.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
Item does not contain fulltextOBJECTIVES: Experience with anti-TNF agents for a decade can be used t...
OBJECTIVES: Experience with anti-TNF agents for a decade can be used to research the safety and effe...
OBJECTIVE: To test the efficacy of standardised monitoring using the disease activity index DAS28 ve...
The effectiveness of biologic disease-modifying antirheumatic drugs (bDMARDs) in the treatment of rh...
Contains fulltext : 81554.pdf (publisher's version ) (Open Access)Despite the avai...
Objectives: To evaluate costs, benefits, and cost effectiveness of tumour necrosis factor inhibitor ...
Item does not contain fulltextOBJECTIVES: To assess the ability of efficacy measures that incorporat...
It has been found that tumour necrosis factor(TNF)-alpha plays a pivotal role in the pathogenesis of...
Contains fulltext : 65606_evalofned.pdf (publisher's version ) (Open Access)The ob...
The objective of this thesis was to explore the value and the validity of data collected in daily cl...
Contains fulltext : 73433.pdf (publisher's version ) (Open Access)The objective of...
AIM: to evaluate the effects of adalimumab, etanercept and infliximab on disease activity, functiona...
Contains fulltext : 70760.pdf (publisher's version ) (Closed access)Aim: to evalua...
BACKGROUND: Randomised controlled trials (RCTs) evaluating the efficacy of antagonists to tumour nec...
Contains fulltext : 47600.pdf (publisher's version ) (Closed access)OBJECTIVE: To ...
Item does not contain fulltextOBJECTIVES: Experience with anti-TNF agents for a decade can be used t...
OBJECTIVES: Experience with anti-TNF agents for a decade can be used to research the safety and effe...
OBJECTIVE: To test the efficacy of standardised monitoring using the disease activity index DAS28 ve...
The effectiveness of biologic disease-modifying antirheumatic drugs (bDMARDs) in the treatment of rh...
Contains fulltext : 81554.pdf (publisher's version ) (Open Access)Despite the avai...
Objectives: To evaluate costs, benefits, and cost effectiveness of tumour necrosis factor inhibitor ...
Item does not contain fulltextOBJECTIVES: To assess the ability of efficacy measures that incorporat...
It has been found that tumour necrosis factor(TNF)-alpha plays a pivotal role in the pathogenesis of...